共 31 条
[1]
Vincent J.(1988)The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects Br J Clin Pharmacol 26 497-502
[2]
Liminana R.(1992)Pharmacokinetic studies of ebastine in rats, dogs and man Drugs Today (Barc) 28 57-67
[3]
Meredith P.A.(1994)Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects Arzneimittelforschung 44 59-64
[4]
Martinez-Tobed A.(1998)N-Dealkylation and hydroxylation of ebastine by human liver cytochrome P450 Drug Metab Dispos 26 566-71
[5]
Tarruús E.(1993)Comparative pharmacokinetics of carebastine/ebastine in moderately renally impaired and healthy volunteers following a single 10mg dose of ebastine: PPDM-8370 [abstract] Pharm Res 10 S390-52
[6]
Segura J.(1996)Cardiac actions of antihistamines Annu Rev Pharmacol Toxicol 36 233-8
[7]
Yamaguchi T.(1999)H1-receptor antagonists: safety issues Ann Allergy Asthma Immunol 83 481-401
[8]
Hashizume T.(1999)Comparative tolerability of second generation antihistamines Drug Saf 20 385-20
[9]
Matsuda M.(2001)Problems of heart rate correction in assessment of drug-induced QT interval prolongation J Cardiovasc Electrophysiol 12 411-54
[10]
Hashizume T.(2005)Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects Br J Clin Pharmacol. 59 346-3